MADRIGAL PHARMACEUTICALS INC (MDGL)
US5588681057 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -444.27M | -373.63M | -295.35M | -241.85M | -202.24M | |||
| Depreciation Amortization | 575.00K | 527.00K | 470.00K | 410.00K | 470.00K | |||
| Change In Working Capital | -6.64M | -3.28M | 37.60M | 30.65M | 23.48M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 61.03M | 52.15M | 32.42M | 26.87M | 20.73M | |||
| OPERATING CASH FLOW | -389.32M | -324.23M | -224.86M | -183.92M | -157.56M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.80M | -1.48M | -220.00K | -210.00K | -330.00K | |||
| Other Investing Activity | -215.80M | -501.04M | 206.90M | -4.85M | 160.11M | |||
| INVESTING CASH FLOW | -217.61M | -502.52M | 206.69M | -5.06M | 159.78M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 30.00M | 65.00M | 50.00M | N/A | N/A | |||
| Stock Issued/Repurchased | 1.09B | 530.48M | 264.34M | 171.24M | 5.09M | |||
| Other Financing Activity | -153.00K | -363.00K | -890.00K | N/A | N/A | |||
| FINANCING CASH FLOW | 1.12B | 595.12M | 313.45M | 171.24M | 5.09M | |||
| CHANGE IN CASH | 509.21M | -231.63M | 295.28M | -17.74M | 7.31M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -389.32M | -324.23M | -224.86M | -183.92M | -157.56M | |||
| Capital Expenditure | -1.80M | -1.48M | -220.00K | -210.00K | -330.00K | |||
| FREE CASH FLOW | -391.11M | -325.71M | -225.08M | -184.13M | -157.89M | |||
All data in USD